Overview

Update
Investments
1 Investment in 1 Company
Total Equity Funding
$58.06M in 3 Rounds from 6 Investors
Headquarters:
San Diego, California
Description:
Tragara is focused on the clinical and commercial development of patented drugs for the treatment of various cancers.
Founders:
Categories:
Pharmaceutical, Health Care, Biotechnology
Website:
http://www.tragarapharma.com
Social:

Company Details

Update

Tragara Pharmaceuticals, Inc. is a pharmaceutical company based in San Diego, California focused on the clinical and commercial development of proprietary drugs for the treatment of various cancers. Tragara launched operations in January 2007 and is focusing its development resources on two proprietary compounds: (1) Capoxigem® (apricoxib; TG01), an oral, potent, and selective inhibitor of cyclooxygenase-2 (COX-2) for the treatment of solid tumors including non-small cell lung cancer, breast cancer, and pancreatic cancer and (2) TG02- multikinase inhibitor for the treatment of hematologic and solid tumors.

Funding Rounds (5) - $63.26M

Update
DateAmount / RoundValuationLead InvestorInvestors
Sep, 2015$13.06M / Venture0
Jul, 2015$1.2M / Debt Financing0
Aug, 2012$4M / Debt Financing0
Apr, 2010$5M / Series B5
Mar, 2007$40M / Series A5

Investments (1)

DateInvested InRoundPartner(s)
Jan, 2009$112.5M / Undisclosed (Lead)

Current Team (1)

Update

News (5)

Update
DateNews
Mar 1, 2015SEC - SEC FORM D
Mar 1, 2015SEC - SEC FORM D
Jul 30, 2013SEC - SEC FORM D
Apr 15, 2010OnBioVC - Tragara raises 5000000 in venture round
Mar 15, 2007PE HUB - PE HUB

Offices/Locations (1)

Update
  • HQ

    10955 Vista Sorrento Parkway, Suite 120

    San Diego, California 92130

    United States

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos